IL17A and colorectal carcinoma: Furthermore, in experimental models of CRC, chemotherapy-stimulated CAFs increase the secretion of specific cytokines, such as IL-17A, which promotes chemoresistance through the NF-κB pathway and increases tumor invasion and growth in vivo.